Analyses of hospitalization of diabetes mellitus patients in Poland by gender, age and place of residence
More details
Hide details
Department of Health Promotion and Postgraduate Education, National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
Department – Centre for Monitoring and Analyses of Population Health, National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
Ann Agric Environ Med. 2013;20(1):61–67
Aim. The purpose of this study was to analyze the hospitalization of diabetes mellitus patients in Polish hospitals in 2005-2009. Materials and Methods. Data was taken from a nationwide database, kept at the National Institute of Public Health – National Institute of Hygiene in Warsaw. Data gathered for this work related to patients whose main cause of hospitalization was diabetes. Results. In the period of five years the number of diabetes-caused hospitalizations increased by nearly 22% – from 172.2 per 100 thousand in 2005 to 209.9 per 100 thousand in 2009. Hospital treatment covered mainly patients suffering from type 2 diabetes (116.4 per 100 thousand in 2009), as well as type 1 diabetes (87.6 per 100 thousand in 2009). Patients under 39 years of age were more often hospitalized because of type 1 diabetes, whereas in the older age groups patients were more often treated in hospitals for type 2 diabetes. Generally, in both types of the disease, older patients required hospitalizations more often than the younger ones. Cardiovascular diseases were the most reported co-morbidity in both types of the disease. In 2005-2009 the hospital mortality rate decreased with regard to both types of diabetes and an average length of hospital stay decreased by one day, reaching 8.1 days in 2009. Conclusion. It must be emphasized that the growing epidemic of diabetes and its complications are an important challenge to society. The percentage of people hospitalized due to diabetes is increasing every year and consumes significant resources dedicated to health care. Early diagnosis and appropriate treatment of diabetes are imperative, as well as reducing the disparities in access to medical care (ambulatory and stationary) for town and country residences.
2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicale Diseases (2008), WHO, Geneva. 5-12.
Roglic G, Unwin N, Bennet PH, et al. The burden of mortality attributable to diabetes. Diabetes Care. 2005; 28: 2130-2135.
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-1053.
International Diabetes Federation. (access: 6.11.2010).
Greeg EW, Cadwell BL, Yrling JC, et al. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. Diabetes Care. 2004; 27: 2806-2812.
Dunstan DW, Zimmet PZ, Welbron TA. The rising prevalence of diabetes and impaired glucose tolerance. Diabetes Care. 2002; 25: 829-834.
Beard HA, Ghatrif MA, Samper-Ternent R, et al. Trends in diabetes prevalence and diabetes-related complications in older Mexican Americans from 1993-1994 to 2004-2005. Diabetes Care. 2009; 32: 2212-2217.
Gale AM. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002; 51: 3353-3361.
The DIAMOND Project Group: Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med. 2006; 23: 857-866.
Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetol. 2003; 46: 182-189.
Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009; 32: 287-294.
Valdes S, Botas P, Delgado E, Diaz Cordorniga F. Mortality in Spanish adults with diagnosed diabetes, undiagnosed diabetes or pre-diabetes. The Asturias study 1998-2004. Rev Esp Cardiol. 2009; 62: 528-534.
Sosnowski C, Janeczko-Sosnowska E, Pasierski T, et al. Wpływ cukrzycy typu 2 na miażdżycę tętnic wieńcowych i obwodowych. Diabetol Doświadczalna Klin. 2005; 5: 433-438.
Heidemann C, Boening H, Pischon T, et al. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer and mortality: a prospective study in the European Prospective Investigation into Cancer and nutrition (EPIC) – Potsdam cohort. Eur J Epidemiol. 2009; 24: 281-288.
Greeg EW, Mangione CM, Cauley JA, et al. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002; 25: 61-67.
Bolin K, Gips C, Mörk AC. et al. Diabetes, health care cost and loss of productivity in Sweden 1987 and 2005 – a register-based approach. Diabetic Med. 2010; 26: 928-934. 17. Dall TM, Zhang Y, Chen YJ. et al. The economic burden of diabetes. Health Affairs 2010; 29: 297-313.
Kanavos P, Aardweg S, Schurer W. Diabetes expenditure, burden of disease and management in 5 EU countries. LSE Health, London School of Economics, January 2012. LSEHealthAndSocialCare/research/LSEHealth/MTRG/LSE_ Diabetes_EXECSUM_24JAN2012.pdf.
International Classification of Diseases (ICD-10). classifications/icd/en/ (access: 22.08.2010).
Wysocki KJ, Zejda JE. Epidemiologia chorób zakaźnych w Polsce w drugiej połowie dwudziestego wieku. Przegl Epidemiol. 2007; 61: 615-628.
Zdrojewski T, Bandosz P, Szpakowski P, et al. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol Pol. 2004; 61(Suppl. 4): 1-26.
Program prewencji i leczenia cukrzycy w Polsce. pl/wwwfiles/ma_struktura/docs/program_cukrzyca_22102009.pdf (access: 18.06.2010).
Lee JM, Okumara MJ, Freed GL, et al. Trends in hospitalizations for diabetes among children and young adults: United States, 1993-2004. Diabetes Care. 2007; 30: 3035-3039.